首页> 外文OA文献 >Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas
【2h】

Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas

机译:1型神经纤维瘤病相关的低度神经胶质瘤:与散发性低度神经胶质瘤的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder, associated with a variable clinical phenotype including cafe-au-lait spots, intertriginous freckling, Lisch nodules, neurofibromas, optic pathway gliomas and distinctive bony lesions. NF1 is caused by a mutation in the NF1 gene, which codes for neurofibromin, a large protein involved in the MAPK- and the mTOR-pathway through RAS-RAF signalling. NF1 is a known tumour predisposition syndrome, associated with different tumours of the nervous system including low grade gliomas (LGGs) in the paediatric population. The focus of this review is on grade I pilocytic astrocytomas (PAs), the most commonly observed histologic subtype of low grade gliomas in NF1. Clinically, these PAs have a better prognosis and show different localisation patterns than their sporadic counterparts, which are most commonly associated with a KIAA1549:BRAF fusion. In this review, possible mechanisms of tumourigenesis in LGGs with and without NF1 will be discussed, including the contribution of different signalling pathways and tumour microenvironment. Furthermore we will discuss how increased understanding of tumourigenesis may lead to new potential targets for treatment. (C) 2016 The Author(s). Published by Elsevier Ireland Ltd.
机译:1型神经纤维瘤病(NF1)是常染色体显性遗传疾病,与可变的临床表型有关,包括咖啡色斑点,三点间雀斑,利希结节,神经纤维瘤,视神经胶质瘤和独特的骨病变。 NF1是由NF1基因的突变引起的,该基因编码神经纤维蛋白,这是一种通过RAS-RAF信号参与MAPK和mTOR途径的大蛋白。 NF1是一种已知的肿瘤易感综合征,与神经系统的各种肿瘤相关,包括小儿人群中的低度神经胶质瘤(LGG)。这篇综述的重点是I级毛细胞星形细胞瘤(PAs),这是NF1中最常见的低级神经胶质瘤的组织学亚型。在临床上,这些PA的预后较好,并且与散发的PA相比,显示出不同的定位模式,后者通常与KIAA1549:BRAF融合相关。在这篇综述中,将讨论在有和没有NF1的LGG中肿瘤发生的可能机制,包括不同信号通路和肿瘤微环境的贡献。此外,我们将讨论对肿瘤发生的更多了解如何导致新的潜在治疗靶标。 (C)2016作者。由Elsevier Ireland Ltd.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号